Member Info for winnings1

RNS today: Chesham House Asset management has built a 12.43% stake.

It never ceases to amaze me how low a share price can go before there is recognition that the price has gone too low. And vise-versa, how high a share price can rise before it is recognized that the rise has gone too high. I think it is called momentum selling/buying. I personally look at fundamentals rather than share price trends to make my buy/sell decisions. Fundamentals here look good to me. Share price deserves to trade region 25p, which is a long way ahead from today's 16.5p. But don't take my word for it,, as always DYOR or speak to your financial adviser.
Cheers.

I also topped up, bought 25k at a little above 16.5p. There was a large seller disposing of half a million shares,
which in my view was the sole cause of the fall. Perhaps we shall know a bit more tomorrow, but meantime
my view on the excellent value here remains unchanged.

I repeat, I see no reason for the fall. I cannot currently think of better a buying opportunity - 16.5p!
But perhaps I am missing something? Has there been a news item somewhere which suggests INSE is not doing well, INSE is heading for the rocks? I doubt it! Topping up is becoming a serious attraction, an opportunity like this is rare, IMHO.

Big dip on small volume. As there is no apparent good reason for the fall, it offers a buying opportunity
for those looking to get in or top up. I hold long term. INSE is a sound outfit operating in a growth market,
making good profits, paying rising dividends. I cannot think of much better value in the market.
IMHO.

Headwinds have dramatically changed to tailwinds, the shares even at current improved price price of 17.125p may well become multi-baggers over the next two to three years. IMHO.

Not difficult to foresee the share price rising jolly substantially, I reckon we may see 20p before very long.

Excellent turnaround, good profit in H1: EPS 1.67p!
Even better, outlook for H2 is robust. Expect full year EPS to come out above 3p.
Makes the shares look rock bottom cheap.
IMHO.

My guess: 15p+ by the end of next week. Today's news is better than excellent.

That is what I would call a scene-changing RNS!
Share price will take a leap north.

Share price has retreated quite a bit recently, at current 277p the shares are beginning to look rather oversold. Right , right now may well prove to be a good time to bu. I But as always DYOR.
I hold long term.

The fall to 62.50p is greatly overdone I maintain that, based on fundamentals, the correct price for APH shares should be 80p+. Once the markets in general stabilize, a speedy correction up the way is on the cards, IMO. Trump took great pride in the rise of the markets, he now must hang his head in shame, as he is to be blamed for the widespread falls, no one likes his threats of trade wars, no one will benefit from trade wars, least of all the American consumers as they will pay higher prices for imported goods. To compete with China, the cost of labour in the US needs to decimate!

Large Biuy-transactions today are indicative of Insttutional interest rising. I can see us heading for 80p plus.

I seen no reason for the share price to have gone as low as 65-66p (today). Indeed in these uncertain times, APH shares should at a premium as the Company operates in what I would call l recession-proof territory. Medicines will not go out of fashion, demand will rise not fall.
I hold long term.

With the share being lower than it should be, and with all that cash in the bank, predator interest could well be aroused.

PM44 - I would think 75p by the end of this week (provided stock markets hold up) and somewhere near 80p by the end of this month as distinctly possible. But, as always, no guarantees in this game. Current weakness substantially due to current general market weakness., IMHO.

Quite some time ago, when the share price shot above 150p, I preached that the rise was overdone and that 80p would be more like fair value. I was ridiculed and aboused, but here we are, the share price is now at or below 80p. Would be nice to see some of the abusers coming forth with an apology, but that would be too much to expect!

Based on fundamentals, the share price has to rise substantially to get back to fair value. The recent fall has
been overdone and has made the shares look cheap at 73.5p. In my view a target price somewhere in the region of 85p-90p would be appropriate.

See RNS today / Several directors buying on the same day, a good sign.

Nice article in The Times today, praising the new anti-nausea medicine (from Alliance) now available to the many pregnant women who suffer nausea in pregnancy. The medical profession has responded very positively in the article. Doctors are pleased to now be able to prescribe a medicine that reduces sickness by 80%. Such a positive article in a prominent paper is bound to give the medicine a flying start. Should help the share price up the way.